Ocular Histoplasmosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2009-04-16
Clinical Trial Update: Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis [Phase 2]
A Phase 2 clinical trial comparing ranibizumab to photodynamic therapy for presumed ocular histoplasmosis, with current status listed as unk…